EGFR signaling stimulates the expression of LSD1 in ovarian cancer cells, and EGFR-LSD1 pathway plays a mechanistic role in the cell migratory activity of EGFR, presumably, via modifying the methylation status of its putative targets [176]. Here, EGFR is linked to ovarian carcinoma.